142 related articles for article (PubMed ID: 28196747)
1. SOCS gene family expression profile in the blood of multiple sclerosis patients.
Toghi M; Taheri M; Arsang-Jang S; Ohadi M; Mirfakhraie R; Mazdeh M; Sayad A
J Neurol Sci; 2017 Apr; 375():481-485. PubMed ID: 28196747
[TBL] [Abstract][Full Text] [Related]
2. Analysis of STAT1, STAT2 and STAT3 mRNA expression levels in the blood of patients with multiple sclerosis.
Manoochehrabadi S; Arsang-Jang S; Mazdeh M; Inoko H; Sayad A; Taheri M
Hum Antibodies; 2019; 27(2):91-98. PubMed ID: 30412483
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Sedeño-Monge V; Arcega-Revilla R; Rojas-Morales E; Santos-López G; Perez-García JC; Sosa-Jurado F; Vallejo-Ruiz V; Solis-Morales CL; Aguilar-Rosas S; Reyes-Leyva J
J Neuroimmunol; 2014 Aug; 273(1-2):117-9. PubMed ID: 24951315
[TBL] [Abstract][Full Text] [Related]
4. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
5. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
[TBL] [Abstract][Full Text] [Related]
6. SOCS3 and SOCS5 mRNA expressions may predict initial steroid response in nephrotic syndrome children.
Ostalska-Nowicka D; Smiech M; Jaroniec M; Zaorska K; Zawierucha P; Szaflarski W; Malinska A; Nowicki M
Folia Histochem Cytobiol; 2011; 49(4):719-28. PubMed ID: 22252769
[TBL] [Abstract][Full Text] [Related]
7. Association between suppressors of cytokine signalling, T-helper type 1/T-helper type 2 balance and allergic sensitization in children.
Daegelmann C; Herberth G; Röder S; Herbarth O; Giese T; Krämer U; Behrendt H; Borte M; Heinrich J; Emmrich F; Lehmann I;
Clin Exp Allergy; 2008 Mar; 38(3):438-48. PubMed ID: 18167120
[TBL] [Abstract][Full Text] [Related]
8. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract][Full Text] [Related]
9. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
[TBL] [Abstract][Full Text] [Related]
10. The expression of SOCS is altered in rheumatoid arthritis.
Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
[TBL] [Abstract][Full Text] [Related]
11. Expression of SOCS1-7 and CIS mRNA in porcine tissues.
Delgado-Ortega M; Melo S; Meurens F
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):493-8. PubMed ID: 21872343
[TBL] [Abstract][Full Text] [Related]
12. STAT5a and STAT6 gene expression levels in multiple sclerosis patients.
Hatami M; Salmani T; Arsang-Jang S; Davood Omrani M; Mazdeh M; Ghafouri-Fard S; Sayad A; Taheri M
Cytokine; 2018 Jun; 106():108-113. PubMed ID: 29126764
[TBL] [Abstract][Full Text] [Related]
13. Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia.
Chen SS; Wu WZ; Zhang YP; Huang WJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5564-5572. PubMed ID: 32495891
[TBL] [Abstract][Full Text] [Related]
14. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
15. Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing-remitting multiple sclerosis.
Pahlevan Kakhki M; Rakhshi N; Heidary M; Behmanesh M; Nikravesh A
J Neurol Sci; 2015 Mar; 350(1-2):40-5. PubMed ID: 25701091
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.
Ghafouri-Fard S; Oskooei VK; Azari I; Taheri M
World J Surg Oncol; 2018 Nov; 16(1):226. PubMed ID: 30453988
[TBL] [Abstract][Full Text] [Related]
17. Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis.
Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A
Arch Neurol; 2011 Jul; 68(7):879-88. PubMed ID: 21403007
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Expression of
Taheri M; Sangseifid S; Shahani P; Eftekharian MM; Arsang-Jang S; Ghafouri-Fard S
Front Immunol; 2021; 12():712859. PubMed ID: 34349769
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polyps.
Bogazzi F; Ultimieri F; Raggi F; Russo D; Costa A; Marciano E; Bartalena L; Martino E
Clin Endocrinol (Oxf); 2009 Jun; 70(6):898-906. PubMed ID: 18844680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]